Artax Biopharma, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2025-07-29. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 46 people.
| Name | Role | Location |
|---|---|---|
| Robert W Armstrong, Ph.D. | Director | Cambridge, MA |
| Casper W Breum | Director | Cambridge, MA |
| Andre W Hoekema | Director | Cambridge, MA |
| Raj W Parekh | Director | Cambridge, MA |
| Gino W Santini | Director | Cambridge, MA |
| Damia W Tormo, Ph.D. | Director | Cambridge, MA |
| Alan W Walts | Director | Cambridge, MA |
| Robert W Armstrong, Ph.D. | Executive Officer | Cambridge, MA |
| Maria W Nichol | Executive Officer | Cambridge, MA |
| Joe W Suarez | Executive Officer | Cambridge, MA |
| Gino Santini | Director | Cambridge, MA |
| Gino Santini | Related Person | Cambridge, MA |
| Robert Armstrong | Director | Cambridge, MA |
| Robert Armstrong | Executive Officer | Cambridge, MA |
| Damia Tormo | Director | Cambridge, MA |
| Damia Tormo | Executive Officer | Cambridge, MA |
| Casper Breum | Director | NESS ZIONA, L3 |
| Casper Breum | Related Person | NESS ZIONA, L3 |
| Alan Walts | Director | Cambridge, MA |
| Alan Walts | Related Person | Cambridge, MA |
| Andre Hoekema | Director | Cambridge, MA |
| Andre Hoekema | Related Person | Cambridge, MA |
| Maria Nichol | Executive Officer | Cambridge, MA |
| Maria Nichol | Related Person | Cambridge, MA |
| Raj Parekh | Director | Waltham, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-05-05 | D/A | $19.0M | $19.0M |
| 2024-08-09 | D | $8.0M | $6.0M |
| 2022-05-18 | D/A | $25.8M | $25.8M |
| 2022-01-03 | D | $23.2M | $12.7M |
| 2021-02-26 | D | $3.0M | $2.2M |
| 2020-05-04 | D | $2.0M | $2.0M |
| 2019-08-12 | D | $3.5M | $750K |
| 2015-10-27 | D | $10.0M | $3.0M |
| 2014-11-10 | D | $2.0M | $2.0M |
| 2013-09-25 | D | $2.0M | $1.3M |